Government issues notification on stockpiling of new drug under phase 3 of clinical trial
Government eases the norms of manufacturing, stocking, sale or distribution of new drugs under phase III clinical trials, for the treatment of Covid-19 and related diseases. The provision is made to stock the drugs with a condition that it will sell the new drug only after obtaining permission as per the regulations.